BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Fish and Richardson

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,395,403

« Back to Dashboard

Summary for Patent: 4,395,403

Title: Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
Abstract:Straight-chain and mono-cyclic polypeptides containing the basic sequence ##STR1## wherein X is an amino acid residue, the residues in the 1- and 6-positions being linked by an --S--S-- bridge when the polypeptide is monocyclic, have pharmacological, in particular GH--, gastric- and pancreatic-secretion inhibiting activity.
Inventor(s): Bauer; Wilfried (Lampenberg, CH), Pless; Janos (Basel, CH)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/321,663
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,395,403

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland10524/79Nov 27, 1979
Switzerland4574/80Jun 13, 1980

International Patent Family for Patent: 4,395,403

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Finland72981► Subscribe
Finland803634► Subscribe
Spain8305701► Subscribe
Germany19375086► Subscribe
Denmark501980► Subscribe
Denmark150146► Subscribe
European Patent Office0029579► SubscribeSPC/GB93/097United Kingdom► Subscribe
Spain497113► Subscribe
Spain8301463► Subscribe
Spain510751► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus